Alannah Smrke
- Oncology top 10%
- Vascular Tumors and Angiosarcomas 4
- Cancer survivorship and care 4
- COVID-19 and healthcare impacts 3
- CAR-T cell therapy research 3
-
- Sarcoma Diagnosis and Treatment 14
-
- Cardiac tumors and thrombi 5
-
- Lymphoma Diagnosis and Treatment 5
-
- Soft tissue tumor case studies 4
- Co-authors
- Robin L. JonesSpyridon GennatasPaul H. HuangPeter M. AndersonAshish GuliaCharlotte BensonChristine SimmonsEve Merry
- Journals
- Journal of Clinical Oncology (2 papers)Annals of Oncology (2 papers)International Journal of Cancer (1 paper)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Alannah Smrke
30 papers receiving 509 citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 238
- Pulmonary and Respiratory Medicine 160
- Cancer Research 62
- Internal Medicine 13
- Public Health, Environmental and Occupational Health 101
Countries citing papers authored by Alannah Smrke
This map shows the geographic impact of Alannah Smrke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alannah Smrke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alannah Smrke more than expected).
Fields of papers citing papers by Alannah Smrke
This network shows the impact of papers produced by Alannah Smrke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alannah Smrke. The network helps show where Alannah Smrke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alannah Smrke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 7 | |
| 7 | 2022 | 0 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 13 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 4 | |
| 14 | Future Directions in the Treatment of Osteosarcomabreakdown → | 2021 | 160 |
| 15 | 2020 | 24 | |
| 16 | 2020 | 19 | |
| 17 | 2020 | 2 | |
| 18 | 2020 | 46 | |
| 19 | 2020 | 19 | |
| 20 | 2017 | 16 |
About Alannah Smrke
Alannah Smrke is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 516 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (14 papers), Cardiac tumors and thrombi (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (4 papers), Soft tissue tumor case studies (4 papers), Cancer survivorship and care (4 papers), COVID-19 and healthcare impacts (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Oncology (238 citations), Pulmonary and Respiratory Medicine (160 citations) and Cancer Research (62 citations). Alannah Smrke has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Robin L. Jones, Spyridon Gennatas, Paul H. Huang, Peter M. Anderson, Ashish Gulia, Charlotte Benson, Christine Simmons, Eve Merry, Olga Husson and Sheima Farag. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.